Caplin Point Laboratories is a finished-dose manufacturer based in India. It appears in 1,112 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO), ARCSA (EC) and MINSA (CR). Customs aggregates show $87.3M of exports covering 3,445 molecules to 21 destinations in 2025.
| Site | FDA FEI |
|---|---|
| CHENNAI, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| DIGEMAPS (DO) | 721 | None |
| ARCSA (EC) | 292 | None |
| MINSA (CR) | 88 | None |
| INVIMA (CO) | 10 | None |
| COFEPRIS (MX) | 1 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $12.6M | 11 |
| 2025 | Not reported | $87.3M | 21 |
| 2024 | Not reported | $87.4M | 19 |
| 2023 | Not reported | $91.3M | 19 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Caplin Point Laboratories comes back tiered against every other supplier able to file there.
Start for free